♫musicjinni

The risks of taking off-brand Ozempic for weight loss, according to a doctor

video thumbnail
The FDA issued a new warning about some of the popular diabetes drugs being used for weight loss after the agency "received adverse event reports after patients used compounded semaglutide." That's the generic name for medications like Ozempic and Wegovy. New York endocrinologist Dr. Florence Comite joins CBS News to discuss the risks of taking off-brand versions.

#news #health #weightloss

CBS News Streaming Network is the premier 24/7 anchored streaming news service from CBS News and Stations, available free to everyone with access to the Internet. The CBS News Streaming Network is your destination for breaking news, live events and original reporting locally, nationally and around the globe. Launched in November 2014 as CBSN, the CBS News Streaming Network is available live in 91 countries and on 30 digital platforms and apps, as well as on CBSNews.com and Paramount+.

Subscribe to the CBS News YouTube channel: http://youtube.com/cbsnews
Watch CBS News: http://cbsn.ws/1PlLpZ7c
Download the CBS News app: http://cbsn.ws/1Xb1WC8
Follow CBS News on Instagram: https://www.instagram.com/cbsnews/
Like CBS News on Facebook: http://facebook.com/cbsnews
Follow CBS News on Twitter: http://twitter.com/cbsnews
Subscribe to our newsletters: http://cbsn.ws/1RqHw7T
Try Paramount+ free: https://bit.ly/2OiW1kZ

For video licensing inquiries, contact: licensing@veritone.com

Diabetes drug Mounjaro could be FDA approved for weight loss by late 2023: Eli Lilly

FDA approves new version of diabetes drug Mounjaro for weight loss

Why so many people are turning to a diabetes drug for weight loss | ABCNL

FDA approves new weight loss drug Zepbound

FDA issues warning for popular diabetes drug used for weight loss

FDA approves diabetes drug to treat obesity

FDA approves new weight loss drug Zepbound

FDA approves new version of diabetes drug Mounjaro for weight loss

Inside the weight loss drug boom | Scripps News Reports

Eli Lilly seeks FDA approval for weight loss drug tirzepatide

Ozempic is a game-changer. Here’s how it works.

Diabetes Drug Ozempic Trends On TikTok As Weight-Loss Drug

Explaining the controversy around new FDA-approved weight loss drugs

Diabetes 101

Weight loss patients eagerly await Ozempic, Mounjaro FDA update | Nightline

Eli Lilly seeking fast-track FDA approval for obesity drug tirzepatide

A popular diabetes drug may become FDA approved for weight loss

FDA-approved weight loss drugs spark controversy over supply for diabetes patients

FDA approved a new version of the diabetes drug Mounjaro for weight loss

Diabetes drug now approved for weight loss

New weight loss drug could break sales records

Diabetes drug Mounjaro could soon be FDA approved for weight loss

FDA approves diabetes drug for weight-loss

Diabetes Drug Could Be Game Changer For Obesity And Weight Loss

Fake weight loss and diabetes drugs entering U.S. market

FDA aproves new version of diabetes drug Mounjaro for weight loss

The weight loss and type 2 diabetes drugs facing shortages | 60 Minutes

FDA approves Eli Lilly’s Zepbound drug for weight loss #shorts

FDA approves new version of diabetes drug Mounjaro for weight loss

The risks of taking off-brand Ozempic for weight loss, according to a doctor

Disclaimer DMCA